Combination of circulating tumor cell enumeration and tumor marker detection in predicting prognosis and treatment effect in metastatic castration-resistant prostate cancer

Although circulating tumor cell (CTC) enumeration in peripheral blood has already been validated as a reliable biomarker in predicting prognosis in metastatic castration-resistant prostate cancer (mCRPC), patients with favorable CTC counts (CTC < 5/7.5 ml) still experience various survival times....

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Kun, Kong, Yun-Yi, Dai, Bo, Ye, Ding-Wei, Qu, Yuan-Yuan, Wang, Yue, Jia, Zhong-Wei, Li, Gao-Xiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747191/
https://www.ncbi.nlm.nih.gov/pubmed/26497689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4747191/
https://www.ncbi.nlm.nih.gov/pubmed/26497689

Ejemplares similares